Cancer Family
Reproductive System Neoplasm
CI-CAN-00000338Explore in graph →
Non-malignant3,042 active trials38 approved drugs197 evidence items
- NCIt
- C3674
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000338Explore in graph →
Clinical trials
13,672 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03382158 | International PPB/DICER1 Registry | recruiting | — | 3,400 | Children's Hospitals and Clinics of MinnesotaOTHER | 1 | Jan 30, 2025 | clinicaltrials |
| NCT04772937 | Comparison of LLETZ Versus LEEP for the Treatment of Cervical Dysplasia | recruiting | N/A | 206 | Ruhr University of BochumOTHER | 1 | Jan 30, 2025 | clinicaltrials |
| NCT06800391 |
| Metronomic Neoadjuvant Capecitabine and Cyclophosphamide in HUGE Pseudomyxoma Peritonei Patients(REVERSE) |
| recruiting |
| Phase 2 |
| 31 |
| Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoOTHER |
| 1 |
| Jan 30, 2025 |
| clinicaltrials |
| NCT06800612 | Evaluating Efficacy and Tolerability of Anticancer Drug Therapies for the Treatment of Gynecologic and Breast Cancers | recruiting | — | 100 | IRCCS Azienda Ospedaliero-Universitaria di BolognaOTHER | 1 | Jan 30, 2025 | clinicaltrials |
| NCT04859530 | Automated Cervical Cancer Screening Using a Smartphone-based Artificial Intelligence Classifier | recruiting | N/A | 5,886 | Prof. Patrick PetignatOTHER | 1 | Jan 29, 2025 | clinicaltrials |
| NCT04957511 | Gut Microbiome and Treatment for Gynecological Cancer Patients Receiving Immunotherapy | recruiting | — | 30 | ViomeINDUSTRY | 1 | Jan 29, 2025 | clinicaltrials |
| NCT06800105 | Dysregulation of Whole-body Metabolism in Ovarian Cancer: A Longitudinal Study | recruiting | — | 10 | University of Tennessee Graduate School of MedicineOTHER | 1 | Jan 29, 2025 | clinicaltrials |
| NCT06630611 | Evaluation of a Pragmatic Approach to Adoptive Cell Therapy (ACT) Using an IL2 Analog (ANV419) vs High Dose IL2 After Tumor Infiltrating Lymphocytes (TIL) Therapy in Patients With Melanoma, NSCLC and Cervical Cancer (PragmaTIL)(PragmaTIL) | recruiting | Phase 2 | 40 | Vall d'Hebron Institute of OncologyOTHER | 1 | Jan 28, 2025 | clinicaltrials |
| NCT06392997 | Evaluation of Salivary RNA in Subjects Scheduled for Surgery for a Gynecologic Pathology(GynRNA) | recruiting | — | 2,500 | ZIWIGINDUSTRY | 1 | Jan 23, 2025 | clinicaltrials |
| NCT06758557 | A Study to Evaluate the Safety and Efficacy of HB0025 Injection in Patients With Advanced Solid Tumor | recruiting | Phase 1 / Phase 2 | 282 | Huabo Biopharm Co., Ltd.INDUSTRY | 1 | Jan 23, 2025 | clinicaltrials |
| NCT05909111 | MR-Only Based Adaptive External Beam Radiation Therapy of Cervical Cancer on Ethos Therapy: Feasibility Study(Ethos Col) | recruiting | N/A | 15 | Recherche cliniqueOTHER | 1 | Jan 22, 2025 | clinicaltrials |
| NCT06782555 | A Study of Evofosfamide in Combination with Zalifrelimab and Balstilimab | recruiting | Phase 1 / Phase 2 | 71 | ImmunoGenesisINDUSTRY | 1 | Jan 21, 2025 | clinicaltrials |
| NCT06784986 | Impact of Using the Airseal System With Ultra-low Pneumoperitoneum in Patients Undergoing Robot-assisted Radical Prostatectomy: A Prospective, Comparative, Randomized Clinical Study.(ARCO2) | recruiting | Phase 4 | 200 | Brazilian Institute of Robotic SurgeryOTHER | 1 | Jan 20, 2025 | clinicaltrials |
| NCT06785077 | Genetic Landscape in Women with Metastatic Ovarian Cancer Before and During Treatment with PARP Inhibitors | recruiting | N/A | 157 | European Institute of OncologyOTHER | 1 | Jan 20, 2025 | clinicaltrials |
| NCT03624712 | Analysis and Optimization of Predictive and Therapeutic Models in Uterine Neoplasms | recruiting | — | 580 | University Hospital TuebingenOTHER | 1 | Jan 17, 2025 | clinicaltrials |
| NCT06554587 | Investigation of Three Biomarkers for the Detection of Prostate Cancer | recruiting | — | 137 | Medtechtomarket Consulting LtdINDUSTRY | 1 | Jan 17, 2025 | clinicaltrials |
| NCT04846933 | Multi-layer Data to Improve Diagnosis, Predict Therapy Resistance and Suggest Targeted Therapies in HGSOC(DECIDER) | recruiting | N/A | 200 | Turku University HospitalOTHER_GOV | 1 | Jan 16, 2025 | clinicaltrials |
| NCT06775470 | Impact of Different BRCA1/2 Gene Variants on Response to Therapy and Prognosis of Ovarian Cancer | recruiting | — | 300 | IRCCS Azienda Ospedaliero-Universitaria di BolognaOTHER | 1 | Jan 15, 2025 | clinicaltrials |
| NCT06777082 | Role of RPL8 Protein Alterations in High-grade Serous Ovarian Carcinoma(OVCAR) | recruiting | — | 150 | IRCCS Azienda Ospedaliero-Universitaria di BolognaOTHER | 1 | Jan 15, 2025 | clinicaltrials |
| NCT04061967 | Research Project on Reminders and Self-Sampling Can Increase Participation in Gynecology Cell Sampling - Preventive Examination Against Cervical Cancer. | recruiting | N/A | 20,000 | Karolinska InstitutetOTHER | 1 | Jan 14, 2025 | clinicaltrials |
| NCT06773598 | Validation of a Machine Learning Model Based on MR for the Prediction of Prostate Cancer | recruiting | — | 1,100 | IRCCS Azienda Ospedaliero-Universitaria di BolognaOTHER | 1 | Jan 14, 2025 | clinicaltrials |
| NCT06774209 | Multimodal PET Imaging in the Diagnosis and Treatment of Pelvic Tumors | recruiting | N/A | 30 | Peking Union Medical College HospitalOTHER | 1 | Jan 14, 2025 | clinicaltrials |
| NCT06774482 | Evaluation of Toxicity and Outcomes of Different Therapeutic Strategies in Patients With Uterine Neoplasms | recruiting | — | 3,000 | IRCCS Azienda Ospedaliero-Universitaria di BolognaOTHER | 1 | Jan 14, 2025 | clinicaltrials |
| NCT06774781 | Assessment of ADC Values and Radiomics Characteristics With a MRI of the Prostate to Identify Tumor Lesions | recruiting | — | 120 | IRCCS Azienda Ospedaliero-Universitaria di BolognaOTHER | 1 | Jan 14, 2025 | clinicaltrials |
| NCT06307886 | Comparison of Five-year Survival and Disease-free Survival in Patients Diagnosed With Endometrium Cancer Who Underwent Total Laparoscopic Hysterectomy With and Without Uterine Manipulator | recruiting | — | 108 | Gaziosmanpasa Research and Education HospitalOTHER_GOV | 1 | Jan 7, 2025 | clinicaltrials |
| NCT06584032 | Study of Fruquintinib Plus Sintilimab for Treatment of Advanced Endometrial Cancer | recruiting | Phase 3 | 412 | HutchmedINDUSTRY | 1 | Jan 7, 2025 | clinicaltrials |
| NCT06760923 | Urinary Proteomic Assessment of Ovarian Malignancy and Disease Progression | recruiting | — | 240 | Xiangya Hospital of Central South UniversityOTHER | 1 | Jan 7, 2025 | clinicaltrials |
| NCT06756334 | Head-to-head Comparison of [18F]AlF-PSMA-N5 With [18F]F-DCFPyL PET/CT in PCa Diagnosis, Recurrence, and Metastasis | recruiting | Early Phase 1 | 30 | Anhui Provincial HospitalOTHER_GOV | 1 | Jan 3, 2025 | clinicaltrials |
| NCT06020755 | Toripalimab Plus Actinomycin-D As Fist-Line Treatment for GTN with FIGO Score 7(TA7) | recruiting | Phase 2 | 17 | Peking Union Medical College HospitalOTHER | 1 | Dec 31, 2024 | clinicaltrials |
| NCT06398613 | Preoperative PSMA PET/CT As Triage for EPLND in Patients Scheduled for RALP (PrePSMA)(PrePSMA) | recruiting | N/A | 600 | Oslo University HospitalOTHER | 1 | Dec 31, 2024 | clinicaltrials |
| NCT06748456 | A Cluster Package Intervention to Promote an Evidence-based Use of PSA-tests in General Practice | recruiting | N/A | 50 | University of CopenhagenOTHER | 1 | Dec 27, 2024 | clinicaltrials |
| NCT06751303 | Patient Preferences for Precision Medicine: Determining Optimal Patient Quality of Life Using PARPi's(4PDQ) | recruiting | N/A | 100 | University of SaskatchewanOTHER | 1 | Dec 27, 2024 | clinicaltrials |
| NCT06640959 | Chronic Radiation Induced Bowel Toxicity Study(CRIBS) | recruiting | — | 50 | The Christie NHS Foundation TrustOTHER | 1 | Dec 20, 2024 | clinicaltrials |
| NCT06684327 | Multi-cohort, Single-arm Phase II Study of Albumin-paclitaxel, Ifosfamide, and Cisplatin in the Treatment of Rare Advanced Tumors | recruiting | Phase 2 | 100 | Fudan UniversityOTHER | 1 | Dec 20, 2024 | clinicaltrials |
| NCT06696326 | A Multicenter Study Evaluating the Diagnostic Value of 68Ga-MY6349 PET/CT for Prostate Cancer | recruiting | N/A | 100 | The First Affiliated Hospital of Xiamen UniversityOTHER | 1 | Dec 18, 2024 | clinicaltrials |
| NCT05989854 | The Remote Study: Investigating the Effects or Online Exercise on Quality of Life in Men With Prostate Cancer | recruiting | N/A | 50 | University of SurreyOTHER | 1 | Dec 17, 2024 | clinicaltrials |
| NCT05855941 | Prognostic and Diagnostic Added Value of Medical Imaging in Gynecological Cancer (PRODIGYN)(PRODIGYN) | recruiting | — | 120 | Region VästerbottenOTHER_GOV | 1 | Dec 16, 2024 | clinicaltrials |
| NCT06735326 | Fluzoparib With or Without Bevacizumab for Neoadjuvant Therapy in Advanced Ovarian Cancer | recruiting | Phase 2 | 105 | Qilu Hospital of Shandong UniversityOTHER | 1 | Dec 16, 2024 | clinicaltrials |
| NCT06736054 | A Phase I Trial of 61Cu-NODAGA-PSMA for Patients with Prostate Cancer | recruiting | Phase 1 | 8 | Hoag Memorial Hospital PresbyterianOTHER | 1 | Dec 16, 2024 | clinicaltrials |
| NCT04113122 | Senescence and the Early Ageing Phenotype After Chemotherapy for Testicular Cancer: the SEA-CAT Study | recruiting | N/A | 192 | University Medical Center GroningenOTHER | 1 | Dec 13, 2024 | clinicaltrials |
| NCT05349227 | Comprehensive Outcomes for After Cancer Health(COACH) | recruiting | N/A | 625 | Pack HealthINDUSTRY | 1 | Dec 11, 2024 | clinicaltrials |
| NCT06726291 | Akynzeo as Antiemetic Treatment in Patients With Endometrial Cancer(NOEME) | recruiting | Phase 4 | 84 | Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoOTHER | 1 | Dec 10, 2024 | clinicaltrials |
| NCT06236373 | The Unmet Needs of Cancer Survivors in Ausl IRCCS Reggio Emilia(Survivorship) | recruiting | — | 45 | University of Modena and Reggio EmiliaOTHER | 1 | Dec 9, 2024 | clinicaltrials |
| NCT05655260 | PErsonalized TReatment for Endometrial Carcinoma(PETREC) | recruiting | N/A | 300 | University of HelsinkiOTHER | 1 | Dec 6, 2024 | clinicaltrials |
| NCT02573636 | The Predictive Value of Coexisting TMPRSS2-ERG Gene Fusion and PTEN Deletion in Prostate Cancer Patients with Biochemical Failure Status Post Salvage or Radical Radiation Therapy | recruiting | — | 208 | Sir Mortimer B. Davis - Jewish General HospitalOTHER | 1 | Dec 4, 2024 | clinicaltrials |
| NCT04896801 | MR-guided Prostate Stereotactic Body Radiotherapy in Seven Days(Proseven) | recruiting | N/A | 132 | Universitair Ziekenhuis BrusselOTHER | 1 | Dec 4, 2024 | clinicaltrials |
| NCT05214937 | A Intervention for Reducing Sedentary Behaviour Among Prostate Cancer Survivors | recruiting | N/A | 120 | University of TorontoOTHER | 1 | Dec 4, 2024 | clinicaltrials |
| NCT06278857 | SATELLITE Study (feaSibility sAfeTy Efficacy dostarLimab earLy-stage defIcient endomeTrial cancEr)(SATELLITE) | recruiting | Phase 2 | 10 | Queensland Centre for Gynaecological CancerOTHER_GOV | 1 | Dec 3, 2024 | clinicaltrials |
| NCT06582628 | Talazoparib Plus Enzalutamide After Progression to Abiraterone in Metastatic Prostate Cancer: (TEAM PC)(TEAM PC) | recruiting | Phase 2 | 78 | Fundacion OncosurNETWORK | 1 | Dec 2, 2024 | clinicaltrials |
| NCT06709326 | APACA-Apheresis/acoustophoresis and Molecular Characterization of Prostate Cancer | recruiting | N/A | 130 | Umeå UniversityOTHER | 1 | Nov 29, 2024 | clinicaltrials |
Data updated 23 days agoSource updated Jan 30, 2025source: clinicaltrials